Authors: Barkholt, L Hentschke, P Zetterquist, H Mattsson, J Uzunel, M Wersall, P Martola, J Albin, N Aschan, J Wijkstrom, H Tillegard, A Oman, S Wernerson, A Niederwieser, D Thorne, A Ringden, O

Citation: L. Barkholt et al., An allogeneic anti-cancer effect after hematopoietic stem cell transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1862-1864

Authors: Mattsson, J Uzunel, M Remberger, M Ljungman, P Kimby, E Ringden, O Zetterquist, H

Citation: J. Mattsson et al., Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease, LEUKEMIA, 14(2), 2000, pp. 247-254

Authors: Zetterquist, H Mattsson, J Uzunel, M Nasman-Bjork, I Svenberg, P Tammik, L Bayat, G Winiarski, J Ringden, O

Citation: H. Zetterquist et al., Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia, BONE MAR TR, 25(8), 2000, pp. 843-851

Authors: Ringden, O Soderdahl, G Mattsson, J Uzunel, M Remberger, M Hentschke, P Hagglund, H Sparrelid, E Elmhorn-Rosenborg, A Duraj, F Zetterquist, H Ericzon, BG

Citation: O. Ringden et al., Transplantation of autologous and allogeneic bone marrow with liver from acadaveric donor for primary liver cancer, TRANSPLANT, 69(10), 2000, pp. 2043-2048

Authors: Lindforss, U Fredholm, H Papadogiannakis, N Gad, A Zetterquist, H Olivecrona, H

Citation: U. Lindforss et al., Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma, CANCER, 88(12), 2000, pp. 2661-2667